DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Gadodiamide
Gadodiamide
ACR Manual on Contrast Media
FDA Warns That Gadolinium-Based Contrast Agents (Gbcas) Are Retained in the Body; Requires New Class Warnings
Gadolinium Based Contrast Agents
DISSERTATION INVESTIGATION of CATIONIC CONTRAST-ENHANCED COMPUTED TOMOGRAPHY for the EVALUATION of EQUINE ARTICULAR CARTILAGE Su
Advisory Committee Briefing Document Medical Imaging Drugs Advisory Committee (MIDAC) September 8, 2017
Estonian Statistics on Medicines 2016 1/41
Guideline on the Use of Gadolinium-Containing MRI Contrast Agents in Patients with Renal Impairment
Art. 31 Gadolinium
Active Moiety Name FDA Established Pharmacologic Class (EPC) Text
PART VI Summary of Activities in the Risk Management Plan by Product
Application for Inclusion of Gadolinium-Based Contrast Agents to the WHO
Estonian Statistics on Medicines 2013 1/44
EMA's Final Opinion Confirms Restrictions on Use of Linear
FDA Listing of Established Pharmacologic Class Text Phrases January 2021
Chapter 1: Introduction and Background…………………………………………….…...1
Gadolinium Containing Contrast Agents
Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: the Physio-Pathological Conditions for the Perfect Murder
Manual on Contrast Media Version 7 2010
Top View
PRODUCT MONOGRAPH OMNISCAN (Gadodiamide Injection
Contrast Media Tutorial
Safety Evaluation of Linear and Macrocyclic Gadolinium-Based
Gadolinium Contrast Media Are More Nephrotoxic Than a Low Osmolar
ACR Manual on Contrast Media (2020)
Intrathecal Use of Gadobutrol for Glymphatic MR Imaging: Prospective Safety Study of 100 Patients
Biem Pharmaceuticals Is
Provisional Peer-Reviewed Toxicity Values for Stable (Nonradioactive) Gadolinium (Casrn 7440-54-2) and Soluble Salts
Combined Index to USP 42 and NF 37, Volumes 1–5, Including Second Supplement
Gadolinium Containing Contrast Agents (Gdcas) Are Complexes of Paramagnetic Gadolinium (III) with Different Types of Organic Chelators
Viewed in Detail Elsewhere [7–10]
)&F1y3x PHARMACEUTICAL APPENDIX to THE
Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution
National Licensed Medicine List of Afghanistan
Questions & Answers Re NSF and Gadolinium, 26 June 2007
Pharmacologyonline 3: 728-781 (2010) Newsletter Bradu and Rossini
GE Healthcare Omniscan™ (Gadodiamide)
Safety and Clinical Usefulness of Gadoteric Acid Including Post-Marketing Surveillance
Gadolinium Contrast Agents and Risk of Tissue Accumulation Removal Of
Optimark® Injection 0.1 Mmol/Kg
Gadolinium-Containing Agents Restrictions on Use
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Contrast Dye Poster Back3
Pharmacokinetics Uses and Administration Adverse Effects And
Guidance on Gadolinium-Based Contrast Agent Administration to Adult Patients
Assessment Report
Dear Healthcare Professional Gadolinium Contrast Agents and Risk
Adverse Reaction Tracking (GMRA) Version 1.1 Patch 1008
12 MR Contrast Agents
Notes on Radiographic Contrast Agents
Histological and SEM Assessment of Blood Stasis in Kidney Blood Vessels After Repeated Intra-Arterial Application of Radiographic Contrast Media
204781Orig1s000
4,436 Reports from Italy, Accepted in the Who Upm
Medicines Adverse Reactions Committee
Application for Inclusion of Gadoterate Meglumine Pdf, 853Kb
17 Gadolinium Contrast Media for Radiographic Examinations Henrik S
MRI Contrast Agents: Classification and Application (Review)
Noninterpretive Skills Study Guide I Table of Contents, Continued
Resolution Ap (2000) 1
Gadolinium Deposition in Brain After Intravenous Injection of Gadolinium-Based Contrast Agents
Pharmacology Part 5: Ct and Mri Contrast